Literature DB >> 114568

The effect of TRH on the release of TSH, PRL and GH in man under basal conditions and following methysergide.

R Collu.   

Abstract

Pretreatment with methysergide, a blocker of serotoninergic receptors, significantly reduced the TSH response to TRH in six male volunteers. The TRH-induced PRL release was also slightly decreased, while plasma GH levels were not significantly modified by TRH either during the control period or after methysergide. These results indicate that alterations of central nervous system monoaminergic pathways may modify the hypophysiotropic effects of TRH.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 114568     DOI: 10.1007/BF03350358

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.

Authors:  I Creese; D R Burt; S H Synder
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

2.  A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.

Authors:  D S SCHALCH; M L PARKER
Journal:  Nature       Date:  1964-09-12       Impact factor: 49.962

3.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

4.  Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.

Authors:  M Irie; T Tsushima
Journal:  J Clin Endocrinol Metab       Date:  1972-07       Impact factor: 5.958

5.  Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

Authors:  K Maeda; Y Kato; N Yamaguchi; K Chihara; S Ohgo
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

6.  Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine.

Authors:  R Collu; M J Clermont; J R Ducharme
Journal:  Eur J Pharmacol       Date:  1976-05       Impact factor: 4.432

7.  Responses to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men.

Authors:  D Gonzalez-Barcena; A J Kastin; D S Schalch; M Torres-Zamora; E Perez-Pasten; A Kato; A V Schally
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

8.  Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism.

Authors:  R Collu; G Leboeuf; J Letarte; J R Ducharme
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

9.  Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.

Authors:  C Ferrari; A Paracchi; M Rondena; P Beck-Peccoz; G Faglia
Journal:  Clin Endocrinol (Oxf)       Date:  1976-09       Impact factor: 3.478

10.  Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep.

Authors:  K Chihara; Y Kato; K Maeda; S Matsukura; H Imura
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

View more
  1 in total

1.  Persistent effects of a marathon run on the pituitary-testicular axis.

Authors:  H Tanaka; J Cléroux; J de Champlain; J R Ducharme; R Collu
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.